Patients who did not complete a distress screener were also less likely to receive autologous stem cell transplants.

Groundbreaking research at the Yale Cancer Center offered hope for patients diagnosed with Multiple Myeloma, a type of blood ...

The firm's LLM-based platform abstracted complex information from medical charts with up to 100 percent accuracy in a pilot study of breast cancer patients.

The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.

Seymour said the Government had, in 2024, allocated Pharmac its largest-ever budget of $6.294 billion over four years, plus a ...

At the Tandem Meetings 2025, researchers presented a study of scalp cooling in patients undergoing chemotherapy and ASCT.

Craig Emmitt Cole, M.D. is a board-certified Hematologist who received his Bachelor of Science degree in physiology at ...

I was in heart failure.” ‘I was in bed for a year’ Jensen-Munroe said she was “absolutely stunned” when told she likely had ...

GLP-1 RA use was associated with significantly lower risks for myeloid leukemia, lymphoid leukemia, non-Hodgkin lymphoma, MDS ...

Regeneron Pharmaceuticals has received a positive opinion from the European Medicines Agency’s human medicines committee for the use of its investigational bispecific antibody linvoseltamab in ...